VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AMSAmerican Shared Hospital Services
$1.64$11M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAMSCash Flow

American Shared Hospital Services (AMS) Cash Flow Statement

30Y historyFree accessUpdated daily

Capital intensity remains a major headwind, with CapEx/Revenue ratios reaching as high as 65.7% in 2025Q1, contributing to erratic free cash flow performance.

AMS Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations2.74M3.1B167K5.72M7.24M6.27M9.74M8.05M8.06M7.85M8.38M8.55M6.77M8.08M6.87M6.82M7.18M7.7M8.95M8.48M9.16M8.48M7.61M8.14M4.19M4.17M2.52M3.59M7.73M7.27M8.8M
Operating CF Margin %-11031.98%0.59%26.81%36.64%35.55%54.63%39.05%40.89%40.16%44.8%51.66%43.93%45.93%40.3%30.71%43.08%45.94%46.85%37.5%44.95%46.51%46.42%50.32%31.33%35.43%26.94%50.13%21.99%19.56%23.78%
Operating CF Growth %-245.98%1854989.82%-97.08%-20.97%15.45%-35.69%21.1%-0.19%2.66%-6.27%-1.99%26.21%-16.13%17.54%0.7%-5.03%-6.75%-13.89%5.46%-7.42%8.07%11.46%-6.54%94.36%0.53%65.65%-29.89%-53.6%6.33%-17.38%79.59%
Net Income-1.54M-2.73B1.53M265K1.55M194K-7.72M1.43M1.63M2.94M2.25M-576K-562K-113K813K1.49M806K466K477K951K1.66M1.77M1.99M1.38M1.1M1.07M1.31M2.71M20.05M1.52M-400K
Depreciation & Amortization5.71B5.71B6.17M5.17M4.78M5.28M6.97M7.41M6.82M6.68M6.33M6.19M6.38M6.41M6.1M6.27M6M6.49M6.71M6.11M5.96M5.5M4.89M4.31M3.53M3M2.36M1.62M6.09M6.75M7M
Stock-Based Compensation403.81M404M373K389K399K0299K230K223K323K215K226K138K88K74K125K110K135K137K69M39M0000000000
Deferred Taxes-809M-809M-359K-759K344K60K-2.16M-444K48K-1.27M772K298K76K59K25K76K168K409K365K536K852K121K264K669K207K383K00-164K00
Other Non-Cash Items-2.58B515.91M-607K952K450K1.58M8.54M361K39K707K526K2.11M517K1.19M-127K-72K110K1K795K-67.61M-37.64M1.13M983K928K3K0-25K-385K-20.48M-821K-100K
Working Capital Changes-70K85K-6.95M-294K-296K-853K3.82M-941K-696K-1.53M-1.71M301K221K438K-10K-1.07M99K201K458K-503K-663K-36K-516K848K-653K-288K-1.13M-356K2.23M-182K2.3M
Change in Receivables-1.68M-559K-6.94B-719K696K-519K2.97M-1.19M-420K-860K-1.23M178K1.07M-643K655K-961M0573M686M-786M-331M-1.07B-483M104M-202M000000
Change in Inventory0000000000000000000000000000000
Change in Payables328K-955K2.23B-79K608K851K263K28K115K125M-199M175K-859M1.02B-349M957M0-262M-214M179M-120M938M104M318M-376M000000
Cash from Investing-3.66M-7.63B-7.11M-6.27M-388K-1.67M-2.39M-990K-1.53M-653K-1.61M-1.93M-4.45M-1.72M-6.67M-4.14M-315K-10.14M830K-15.67M-4.75M-12.57M-1.32M-731K-1.06M-714K-277K629K11.64M-223K-300K
Capital Expenditures-3.66M-7.63B-7.94M-6.27M-388K-1.67M-455K-990K-1.58M-803K-1.61M-1.92M-5.21M-1.71M-6.63M-5.61M-315K-1.15M-4.31M-16.33M-5.15M-6.2M-368K-731K-1.35M-724K-542K-131K-746K-349K-300K
CapEx % of Revenue12.6%27184.67%28.01%29.42%1.97%9.5%2.55%4.8%8%4.11%8.62%11.58%33.81%9.72%38.91%25.26%1.89%6.83%22.58%72.2%25.24%33.98%2.25%4.52%10.07%6.16%5.81%1.83%2.12%0.94%0.81%
Acquisitions000000-2.08M00150K7K0768K000000007.33B000000000
Investments-------------------------------
Other Investing00833K000150K051K150K0-10K1.36B-14K-31K1.51M0-9B1.47M-617K20K-7.33B-957M0283K10K265K760K12.39M126K-100K
Cash from Financing-5.35M-3.03B4.41M1.91M-2.66M-655K-4.81M-7.07M-7.25M-7.92M-6.1M-5.47M-3.16M-6.02M-1.22M-1.54M-6.26M-7.01M-5.83M9.57M-1.76M-2.73M-8.47M-7.02M-4.78M-4.29M-2.72M-2.43M-8.28M-7.4M-8.6M
Debt Issued (Net)-5.21M-3.01M4.63M2.12M-2.03M255K-4.05M-6.17M-6.56M-7.27M-6M-13.85M-4.13M-5.41M-631K-542K-5.64M-8.33M-4.59M11.31M-17K-404K-1.43M-579K-4.43M-3.35M-2.28M-1.2M-8.2M-7.4M-8.6M
Equity Issued (Net)00005K5K0000220K01.8M0-28K00-271K-443K05K-513K-5K11K91K-580K-443K-1.2M-2K00
Dividends Paid0000000000000000000-715K-954K-1.81M-1.1M-610K-438K-361K00000
Share Repurchases000000000000-2K0-28K0-443M-271K-443K00-670K-45K-14K-135K-596K-443K-1.2M-2K00
Other Financing-146K-3.02B-221K-211K-630K-915K-761K-897K-690K-551K-692K7.36M-834K-608K-563K-996K-627K1.59M-798K-1.03M-798K-912K-7.04M-5.84M000-27K-73K00
Net Change in Cash-6.27M-7.56B-2.53M1.35M4.19M3.94M2.55M-13K-710K-719K662K1.15M-850K345K-1.02M1.14M605K-9.45M3.95M2.39M2.65M-6.82M-2.19M388K-1.66M-841K-482K1.79M11.1M-351K-8.6M
Free Cash Flow-916K-4.54B-7.77M-555K6.85M4.59M9.29M7.06M6.49M7.05M6.77M6.63M1.56M6.37M237K1.21M6.87M6.56M4.63M-7.85M4.02M2.29M7.24M7.41M2.84M3.44M1.97M3.46M6.99M6.92M8.5M
FCF Margin %-3.15%-16152.7%-27.42%-2.6%34.68%26.06%52.08%34.25%32.9%36.05%36.18%40.08%10.13%36.2%1.39%5.45%41.19%39.12%24.26%-34.7%19.71%12.53%44.18%45.8%21.26%29.27%21.13%48.3%19.87%18.62%22.97%
FCF Growth %85.31%-58270.87%-1300.18%-108.11%49.07%-50.56%31.64%8.82%-8.01%4.2%2.02%324.86%-75.48%2586.08%-80.41%-82.38%4.73%41.54%159.04%-295.35%75.84%-68.44%-2.28%160.7%-17.43%74.46%-42.91%-50.52%0.91%-18.56%80.85%
FCF per Share-0.14-685.61-1.16-0.091.090.761.501.191.081.211.241.220.311.430.050.261.491.400.93-1.570.800.451.421.540.590.970.510.871.461.101.70
FCF Conversion (FCF/Net Income)0.59x-1994.85x0.08x9.37x5.45x32.30x-1.38x12.21x7.88x4.08x9.01x-5.62x-7.11x-25.88x180.82x13.48x126.04x-40.98x18.76x8.92x5.53x4.80x3.83x5.89x3.80x3.90x1.92x1.33x0.39x4.78x-22.00x
Interest Paid606K1.38M1.4M1.07M722K0938K1.32M1.61M1.57M2.15M1.67M2.07M2.12M2.35M2.5M2.45M2.35M2.9M000000000000
Taxes Paid474K739K1.85M297K169K0339K397K459K126K266K25K41K44K158K90K88K31K261K000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Capital intensity versus utilization

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings and Cash Flow Disconnect

As reported in recent financial statements, the persistent gap between net income and operating cash flow suggests that AMS relies heavily on non-cash adjustments, with OCF/NI ratios frequently reaching extreme levels, such as the -3.51 observed in 2026Q1, indicating poor quality of earnings.

The frequent divergence between accounting losses and operating cash flow highlights a reliance on significant depreciation and amortization to mask underlying operational cash burn. Investors should monitor whether this pattern reflects a structural inability to convert clinical service revenue into actual liquidity.

Free Cash Flow Volatility Persists

Based on the company's quarterly filings, free cash flow remains highly erratic, swinging from a positive $2.1M in 2026Q1 to a deep deficit of -$4.4M in 2024Q4, reflecting the lumpy nature of capital expenditures relative to the company's limited revenue base.

The inability to maintain consistent positive free cash flow suggests that the current business model is highly sensitive to the timing of equipment maintenance and upgrades. This volatility complicates long-term financial planning and may necessitate external financing to sustain operations.

Capital Intensity Strains Liquidity Position

According to historical data, AMS maintains a high capital intensity, with CapEx/Revenue ratios occasionally exceeding 50%, such as the 65.7% recorded in 2025Q1, which underscores the heavy burden of maintaining specialized medical equipment in a low-growth environment.

The high proportion of revenue directed toward capital expenditures suggests that the company is trapped in a cycle of constant reinvestment just to maintain its existing fleet. This capital-heavy profile limits the firm's ability to pivot toward higher-margin growth opportunities without further straining its cash reserves.

Working Capital Fluctuations Impact Liquidity

As evidenced by the quarterly cash flow data, working capital changes have been a significant source of volatility, with swings ranging from a $1.7M inflow in 2025Q1 to a $4.0M outflow in 2023Q4, suggesting inconsistent efficiency in managing receivables and payables.

These sharp fluctuations in working capital may indicate challenges in the timing of collections from hospital partners or potential inefficiencies in inventory management for specialized parts. Such instability in cash conversion cycles warrants further investigation into the company's underlying credit and payment terms.

AMS — Frequently Asked Questions

Quick answers to the most common questions about buying AMS stock.

How much cash does American Shared Hospital Services (AMS) generate from operations?

American Shared Hospital Services (AMS) generated $3.10B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is American Shared Hospital Services's free cash flow?

American Shared Hospital Services (AMS) reported negative free cash flow of $4.54B in 2025, indicating capital requirements exceeded cash from operations.

What is American Shared Hospital Services's capital expenditure (CapEx)?

American Shared Hospital Services (AMS) spent $7.63B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.